🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
February 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — February 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1586)
All (1586)
Buys (171)
Sells (1415)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Tenaya Therapeutics, Inc.
(TNYA)
COLUMN GROUP III GP, LP
— 10% Owner
Feb 11, 2026
Sale
Shares
2,151,458
Price
$0.68
Total Value
$1.46M
Shares Held After
2,651,817
% of Holdings
44.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tenaya Therapeutics, Inc.
(TNYA)
COLUMN GROUP III GP, LP
— 10% Owner
Feb 11, 2026
Sale
Shares
1,905,115
Price
$0.68
Total Value
$1.30M
Shares Held After
2,348,183
% of Holdings
44.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
3,961
Price
$73.25
Total Value
$290.15K
Shares Held After
4,478,447
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
4,404
Price
$72.65
Total Value
$319.94K
Shares Held After
4,482,408
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
3,775
Price
$71.46
Total Value
$269.75K
Shares Held After
4,486,812
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
7,860
Price
$70.70
Total Value
$555.71K
Shares Held After
4,490,587
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
3,994
Price
$73.25
Total Value
$292.57K
Shares Held After
675,686
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
4,484
Price
$72.64
Total Value
$325.70K
Shares Held After
679,680
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
3,716
Price
$71.44
Total Value
$265.48K
Shares Held After
684,164
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 11, 2026
Sale
Shares
7,806
Price
$70.69
Total Value
$551.80K
Shares Held After
687,880
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Ambrose Kristen
— SVP & Chief Accounting Officer
Feb 11, 2026
Sale
Shares
1,376
Price
$460.43
Total Value
$633.55K
Shares Held After
10,127
% of Holdings
12.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Atkinson Edward Morrow III
— EVP, Chief Technical Ops. Off.
Feb 11, 2026
Sale
Shares
1,751
Price
$460.43
Total Value
$806.21K
Shares Held After
22,046
% of Holdings
7.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Biller Jonathan
— EVP and Chief Legal Officer
Feb 11, 2026
Sale
Shares
1,925
Price
$460.43
Total Value
$886.33K
Shares Held After
20,819
% of Holdings
8.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Bunnage Mark E.
— EVP, Chief Scientific Officer
Feb 11, 2026
Sale
Shares
2,021
Price
$460.43
Total Value
$930.53K
Shares Held After
12,914
% of Holdings
13.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tectonic Therapeutic, Inc.
(TECX)
REICIN ALISE
— Director
Feb 11, 2026
Purchase
Shares
2,500
Price
$21.10
Total Value
$52.75K
Shares Held After
237,547
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Tarr Mark J
— Director
Feb 11, 2026
Sale
Shares
213
Price
$113.58
Total Value
$24.19K
Shares Held After
377,070
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Tarr Mark J
— Director
Feb 11, 2026
Sale
Shares
87,745
Price
$113.09
Total Value
$9.92M
Shares Held After
377,283
% of Holdings
18.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Tarr Mark J
— Director
Feb 11, 2026
Sale
Shares
6,057
Price
$111.89
Total Value
$677.72K
Shares Held After
465,028
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Tarr Mark J
— Director
Feb 11, 2026
Sale
Shares
10,954
Price
$110.92
Total Value
$1.22M
Shares Held After
471,085
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Tarr Mark J
— Director
Feb 11, 2026
Sale
Shares
15,584
Price
$110.07
Total Value
$1.72M
Shares Held After
482,039
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Tarr Mark J
— Director
Feb 11, 2026
Sale
Shares
13,231
Price
$108.80
Total Value
$1.44M
Shares Held After
497,623
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Encompass Health Corp
(EHC)
Tarr Mark J
— Director
Feb 11, 2026
Sale
Shares
16,216
Price
$108.03
Total Value
$1.75M
Shares Held After
510,854
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PULSE BIOSCIENCES, INC.
(PLSE)
Danahy Kevin Patrick
— Chief Commercial Officer
Feb 11, 2026
Sale
Shares
20,000
Price
$25.20
Total Value
$504.00K
Shares Held After
43,298
% of Holdings
31.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Feb 11, 2026
Sale
Shares
234
Price
$52.21
Total Value
$12.22K
Shares Held After
50,760
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PHIBRO ANIMAL HEALTH CORP
(PAHC)
BENDHEIM JACK
— Director
Feb 11, 2026
Sale
Shares
13,950
Price
$51.61
Total Value
$719.97K
Shares Held After
50,994
% of Holdings
21.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INTUITIVE SURGICAL INC
(ISRG)
Curet Myriam
— EVP & Chief Medical Officer
Feb 11, 2026
Sale
Shares
421
Price
$494.96
Total Value
$208.38K
Shares Held After
409
% of Holdings
50.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
INTUITIVE SURGICAL INC
(ISRG)
Widman Fredrik
— VP Corporate Controller
Feb 11, 2026
Sale
Shares
133
Price
$494.96
Total Value
$65.83K
Shares Held After
660
% of Holdings
16.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Doximity, Inc.
(DOCS)
Sitaram Siddharth
— Interim PFO and PAO
Feb 10, 2026
Sale
Shares
2,282
Price
$27.88
Total Value
$63.62K
Shares Held After
81,451
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Cannabis Sativa, Inc.
(CBDS)
TOBIAS DAVID
— Director
Feb 10, 2026
Sale
Shares
135,000
Price
$0.02
Total Value
$2.40K
Shares Held After
25,693
% of Holdings
84.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ernexa Therapeutics Inc.
(ERNA)
Cherington Charles
— 10% Owner
Feb 10, 2026
Purchase
Shares
4,000,000
Price
$0.50
Total Value
$2.00M
Shares Held After
6,779,440
% of Holdings
59.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EKSO BIONICS HOLDINGS, INC.
(EKSO)
ASHER DANIEL
— 10% Owner
Feb 10, 2026
Purchase
Shares
10,200
Price
$9.92
Total Value
$101.22K
Shares Held After
171,957
% of Holdings
5.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
Smith Hunter C
— Chief Financial Officer
Feb 10, 2026
Sale
Shares
100
Price
$104.76
Total Value
$10.48K
Shares Held After
122,824
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
Smith Hunter C
— Chief Financial Officer
Feb 10, 2026
Sale
Shares
700
Price
$103.68
Total Value
$72.57K
Shares Held After
122,924
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RHYTHM PHARMACEUTICALS, INC.
(RYTM)
Smith Hunter C
— Chief Financial Officer
Feb 10, 2026
Sale
Shares
1,913
Price
$102.66
Total Value
$196.38K
Shares Held After
123,624
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Insight Molecular Diagnostics Inc.
(IMDX)
BROADWOOD PARTNERS, L.P.
— 10% Owner
Feb 10, 2026
Purchase
Shares
521,739
Price
$5.75
Total Value
$3.00M
Shares Held After
11,931,839
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Malenka Robert C.
— Director
Feb 10, 2026
Sale
Shares
6,622
Price
$18.12
Total Value
$119.99K
Shares Held After
351,611
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Garnett Timothy John
— Director
Feb 10, 2026
Purchase
Shares
14,124
Price
$17.89
Total Value
$252.68K
Shares Held After
14,124
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tenaya Therapeutics, Inc.
(TNYA)
COLUMN GROUP III GP, LP
— 10% Owner
Feb 10, 2026
Sale
Shares
182,295
Price
$0.82
Total Value
$148.77K
Shares Held After
4,803,275
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tenaya Therapeutics, Inc.
(TNYA)
COLUMN GROUP III GP, LP
— 10% Owner
Feb 10, 2026
Sale
Shares
161,422
Price
$0.82
Total Value
$131.74K
Shares Held After
4,253,298
% of Holdings
3.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neuronetics, Inc.
(STIM)
MACAN WILLIAM ANDREW
— EVP, CLO and CS
Feb 10, 2026
Sale
Shares
3,485
Price
$1.55
Total Value
$5.40K
Shares Held After
687,681
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neuronetics, Inc.
(STIM)
Sullivan Keith J
— Director
Feb 10, 2026
Sale
Shares
40,976
Price
$1.55
Total Value
$63.51K
Shares Held After
1,567,012
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
QUEST DIAGNOSTICS INC
(DGX)
Plewman Patrick
— SVP for Diagnostic Services
Feb 10, 2026
Sale
Shares
5,662
Price
$204.00
Total Value
$1.16M
Shares Held After
15,381
% of Holdings
26.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kiniksa Pharmaceuticals International, plc
(KNSA)
Quart Barry D
— Director
Feb 10, 2026
Sale
Shares
110
Price
$45.00
Total Value
$4.95K
Shares Held After
12,546
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 10, 2026
Sale
Shares
5,960
Price
$72.27
Total Value
$430.75K
Shares Held After
4,498,447
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 10, 2026
Sale
Shares
14,040
Price
$71.80
Total Value
$1.01M
Shares Held After
4,504,407
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 10, 2026
Sale
Shares
5,799
Price
$72.28
Total Value
$419.17K
Shares Held After
695,686
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BridgeBio Pharma, Inc.
(BBIO)
Kumar Neil
— Director
Feb 10, 2026
Sale
Shares
14,201
Price
$71.80
Total Value
$1.02M
Shares Held After
701,485
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sagimet Biosciences Inc.
(SGMT)
Rozek Elizabeth
— Chief Legal & Admin. Officer
Feb 10, 2026
Sale
Shares
2,622
Price
$5.36
Total Value
$14.05K
Shares Held After
190,959
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sagimet Biosciences Inc.
(SGMT)
Martins Eduardo Bruno
— Chief Medical Officer
Feb 10, 2026
Sale
Shares
3,640
Price
$5.36
Total Value
$19.51K
Shares Held After
103,296
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sagimet Biosciences Inc.
(SGMT)
Chauche Thierry
— Chief Financial Officer
Feb 10, 2026
Sale
Shares
1,312
Price
$5.36
Total Value
$7.03K
Shares Held After
15,688
% of Holdings
7.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1001–1050 of 1586 transactions (page 21 of 32)
Version: v26.3.29